Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00510133
Status:
COMPLETED
Last Update Posted:
2019-07-09
First Post:
2007-07-30
Brief Title:
A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia AML
Sponsor:
Asterias Biotherapeutics Inc
Organization:
Asterias Biotherapeutics Inc
Organization Data
Organization:
Asterias Biotherapeutics Inc
Class:
INDUSTRY
Study ID:
GRNVAC1 CP06-151
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Asterias Biotherapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None